# EDGAR Filing Document

**Accession Number:** 0000911216
**File Stem:** 0002131234-26-000001
**Filing Date:** 2026-4
**Character Count:** 12805
**Document Hash:** a90287c2bfa9b62cdd39cf2058f219e2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002131234-26-000001.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0002131234-26-000001

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PALATIN TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0000911216
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 954078884
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-46069
- **FILM NUMBER:** 26889274

**BUSINESS ADDRESS:**
- **STREET 1:** 4B CEDAR BROOK DRIVE
- **CITY:** CRANBURY
- **STATE:** NJ
- **ZIP:** 08512
- **BUSINESS PHONE:** 609-495-2200

**MAIL ADDRESS:**
- **STREET 1:** 4B CEDAR BROOK DRIVE
- **CITY:** CRANBURY
- **STATE:** NJ
- **ZIP:** 08512

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERFILM INC
- **DATE OF NAME CHANGE:** 19930825
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AuGC Partners LLC
- **CENTRAL INDEX KEY:** 0002131234

**ORGANIZATION NAME:**
- **EIN:** 811351886
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 10875 KEMAH LANE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131
- **BUSINESS PHONE:** 805-748-8593

**MAIL ADDRESS:**
- **STREET 1:** 10875 KEMAH LANE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131

### Attached PDF Documents

**Attachment 1:** `AuGC_ex1.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** PALATIN TECHNOLOGIES INC

**Title of Class of Securities:** Common Stock, par value $0.01 per share

**CUSIP Number:** —

**Date of Event Which Requires Filing of this Statement:** 04/13/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>AuGC BioFund LP | Names of Reporting Persons<br>AuGC BioFund LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>94212.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>94212.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.3% | Percent of Class Represented by Amount in Row (9)<br>5.3% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

---

| 1. | Names of Reporting Persons<br>AuGC Partners LLC | Names of Reporting Persons<br>AuGC Partners LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>94212.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>94212.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.3% | Percent of Class Represented by Amount in Row (9)<br>5.3% |
| 12. | Type of Reporting Person (See Instructions)<br>IA, HC, OO | Type of Reporting Person (See Instructions)<br>IA, HC, OO |

---

| 1. | Names of Reporting Persons<br>Evan Markegard | Names of Reporting Persons<br>Evan Markegard |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>94212.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>94212.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>94212.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.3% | Percent of Class Represented by Amount in Row (9)<br>5.3% |
| 12. | Type of Reporting Person (See Instructions)<br>HC, IN | Type of Reporting Person (See Instructions)<br>HC, IN |

---

**Item 1(a). Name of Issuer:**
PALATIN TECHNOLOGIES INC

**Item 1(b). Address of Issuer's Principal Executive Offices:**
4B CEDAR BROOK DRIVE, CRANBURY, NEW JERSEY, 08512.

**Item 2(a). Name of Person Filing:**
AuGC BioFund LP

AuGC Partners LLC

Evan Markegard

**Item 2(b). Address of Principal Business Office:**
AuGC BioFund LPc/o AuGC Partners LLC
10875 Kemah Lane
San Diego, CA 92131

AuGC Partners LLC
10875 Kemah Lane
San Diego, CA 92131

Evan Markegardc/o AuGC Partners LLC
10875 Kemah Lane
San Diego, CA 92131

**Item 2(c). Citizenship:**
AuGC BioFund LP - Delaware

AuGC Partners LLC - Delaware

Evan Markegard - United States

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.01 per share

**Item 2(e). CUSIP Number:**
—

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

AuGC Partners LLC is an investment adviser that is registered as an Exempt Reporting Adviser with the Securities and Exchange Commission. AuGC Partners LLC, which serves as investment adviser to  AuGC BioFund LP (the "Fund"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund. Mr. Markegard, as Managing Member of AuGC Partners LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund. Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, AuGC Partners LLC and Mr. Markegard expressly disclaim beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that AuGC Partners LLC or Mr. Markegard are the beneficial owner of any of the securities reported herein.
AuGC BioFund LP - 94,212 shares
AuGC Partners LLC - 94,212 shares
Evan Markegard - 94,212 shares

**(b) Percent of class:**

Ownership percentage is based on 1,772,199 shares of common stock outstanding, par value $0.01 per share, as of February 13, 2026, as reported by the Issuer on Form 10-Q filed with the Securities and Exchange Commission on February 17, 2026.
AuGC BioFund LP - 5.3%
AuGC Partners LLC - 5.3%
Evan Markegard - 5.3%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

AuGC BioFund LP - 0
AuGC Partners LLC - 0
Evan Markegard - 0

**(ii) Shared power to vote or to direct the vote:**

AuGC BioFund LP - 94,212 shares
AuGC Partners LLC - 94,212 shares
Evan Markegard - 94,212 shares

**(iii) Sole power to dispose or to direct the disposition of:**

AuGC BioFund LP - 0
AuGC Partners LLC - 0
Evan Markegard - 0

**(iv) Shared power to dispose or to direct the disposition of:**

AuGC BioFund LP - 94,212 shares
AuGC Partners LLC - 94,212 shares
Evan Markegard - 94,212 shares

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

The Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.

**Item 7. Identification and Classification of the Subsidiary**

See Notes above.

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**AuGC BioFund LP**

**Date:** 04/23/2026

**By:** /s/ Evan Markegard

**Name & Title:** Managing Member, AuGC Partners LLC, its General Partner

**AuGC Partners LLC**

**Date:** 04/23/2026

**By:** /s/ Evan Markegard

**Name & Title:** Managing Member

**Evan Markegard**

**Date:** 04/23/2026

**By:** /s/ Evan Markegard

**Name & Title:** Evan Markegard